Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-31T12:54:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the agency’s transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.2%
    Check dated 2026-10-24T16:27:11.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-17T16:15:28.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-10T16:11:43.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    On 2026-09-17 the study record was updated to revision v3.7.0, introducing Business Reasons and new status fields (Study Status and Recruitment Status). The previous Completed entry from revision v3.6.6 was removed on 2026-06-26.
    Difference
    0.2%
    Check dated 2026-09-19T21:51:37.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The version history now shows the current release as Revision: v3.6.6, replacing the previous Revision: v3.6.5 in the history.
    Difference
    0.0%
    Check dated 2026-08-29T20:56:36.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.